Literature DB >> 22652983

Pathogen identification by nuclear imaging--almost there?

Samir G Agrawal, Stephen J Mather.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22652983     DOI： 10.1007/s00259-012-2165-1

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  16 in total

1.  Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003).

Authors:  Georgios Chamilos; Mario Luna; Russell E Lewis; Gerald P Bodey; Roy Chemaly; Jeffrey J Tarrand; Amar Safdar; Issam I Raad; Dimitrios P Kontoyiannis
Journal:  Haematologica       Date:  2006-06-01       Impact factor: 9.941

2.  Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study.

Authors:  Johan Maertens; Koen Theunissen; Gregor Verhoef; Johnny Verschakelen; Katrien Lagrou; Eric Verbeken; Alexander Wilmer; Jan Verhaegen; Marc Boogaerts; Johan Van Eldere
Journal:  Clin Infect Dis       Date:  2005-09-29       Impact factor: 9.079

3.  The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis.

Authors:  J R Perfect; G M Cox; J Y Lee; C A Kauffman; L de Repentigny; S W Chapman; V A Morrison; P Pappas; J W Hiemenz; D A Stevens
Journal:  Clin Infect Dis       Date:  2001-10-22       Impact factor: 9.079

Review 4.  Optimizing management of invasive mould diseases.

Authors:  Samir Agrawal; William Hope; János Sinkó; Christopher Kibbler
Journal:  J Antimicrob Chemother       Date:  2011-01       Impact factor: 5.790

Review 5.  Aspergillosis case-fatality rate: systematic review of the literature.

Authors:  S J Lin; J Schranz; S M Teutsch
Journal:  Clin Infect Dis       Date:  2001-01-26       Impact factor: 9.079

6.  Aspergillosis caused by non-fumigatus Aspergillus species: risk factors and in vitro susceptibility compared with Aspergillus fumigatus.

Authors:  Harrys A Torres; Gustavo A Rivero; Russell E Lewis; Ray Hachem; Issam I Raad; Dimitrios P Kontoyiannis
Journal:  Diagn Microbiol Infect Dis       Date:  2003-05       Impact factor: 2.803

Review 7.  Galactomannan detection for invasive aspergillosis in immunocompromized patients.

Authors:  Mariska M Leeflang; Yvette J Debets-Ossenkopp; Caroline E Visser; Rob J P M Scholten; Lotty Hooft; Henk A Bijlmer; Johannes B Reitsma; Patrick Mm Bossuyt; Christina M Vandenbroucke-Grauls
Journal:  Cochrane Database Syst Rev       Date:  2008-10-08

8.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Authors:  Ben De Pauw; Thomas J Walsh; J Peter Donnelly; David A Stevens; John E Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas F Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren A Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; John E Bennett
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

9.  Preclinical evaluation of two 68Ga-siderophores as potential radiopharmaceuticals for Aspergillus fumigatus infection imaging.

Authors:  Milos Petrik; Gerben M Franssen; Hubertus Haas; Peter Laverman; Caroline Hörtnagl; Markus Schrettl; Anna Helbok; Cornelia Lass-Flörl; Clemens Decristoforo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-04-24       Impact factor: 9.236

10.  Siderophore biosynthesis but not reductive iron assimilation is essential for Aspergillus fumigatus virulence.

Authors:  Markus Schrettl; Elaine Bignell; Claudia Kragl; Chistoph Joechl; Tom Rogers; Herbert N Arst; Ken Haynes; Hubertus Haas
Journal:  J Exp Med       Date:  2004-10-25       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.